| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 58.894 | 101.016 | 131.944 | 174.606 | 231.960 | 267.460 | 93.923 | 107.688 | 254.001 |
| Total Income - EUR | - | 58.894 | 101.016 | 131.944 | 174.606 | 232.115 | 267.657 | 94.163 | 125.203 | 308.586 |
| Total Expenses - EUR | - | 8.594 | 11.699 | 13.141 | 29.757 | 37.175 | 36.147 | 33.152 | 46.943 | 87.405 |
| Gross Profit/Loss - EUR | - | 50.300 | 89.318 | 118.803 | 144.848 | 194.940 | 231.510 | 61.011 | 78.259 | 221.181 |
| Net Profit/Loss - EUR | - | 49.711 | 88.308 | 117.484 | 143.103 | 192.785 | 229.277 | 60.070 | 77.429 | 186.501 |
| Employees | - | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 |
Check the financial reports for the company - Hortopan Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 67.357 | 46.665 | 26.646 | 7.831 | 188.024 | 139.407 |
| Current Assets | - | 51.166 | 90.063 | 119.393 | 78.361 | 148.750 | 205.196 | 55.665 | 80.002 | 193.312 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 598 | 2.960 | 72.183 | 72.069 | 136.606 | 180.730 | 47.312 | 73.800 | 153.103 |
| Cash | - | 50.568 | 87.103 | 47.211 | 6.292 | 12.144 | 2.229 | 242 | 4.180 | 2 |
| Shareholders Funds | - | 49.755 | 88.351 | 117.527 | 143.145 | 192.834 | 229.326 | 60.118 | 77.477 | 186.549 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.411 | 1.711 | 1.867 | 2.574 | 2.581 | 2.516 | 3.377 | 9.245 | 11.589 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 181.368 | 134.645 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Hortopan Med Srl